Automatic, precise spine reconstruction and labeling – performed by FAST Spine with just a single click – can potentially save up to 30 minutes of precious reconstruction time.
The FAST CARE Technology focuses on two aspects: Fully Assisting Scanner Technologies (FAST) supports process optimization, and Combined Applications to Reduce Exposure (CARE) assists with dose reduction features.
Be FAST
FAST – our Fully Assisting Scanner Technologies – make time-consuming and complex procedures faster as well as far more intuitive. Your scans will be more reproducible and less prone to errors. One of FAST’s valuable features is FAST Spine.
FAST Spine
Delivers an accurate and anatomically aligned reconstruction of the spine with just a single click. This direct detection and labeling of vertebra and spine may save up to 30 minutes of manual preparation for a complete spine reconstruction.
Get your free 90-day trial licensehere
More information about the FAST CARE Technology can be found here
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.